| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 3 | -437,142 | 100% | $8.00 | -$3,496,830 |
| Net | -3 | -437,142 | -100% | -$3,496,830 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jeffrey M. Thompson | Chairman of the Board, CEO, Director, 10%+ Owner | $95,479,582 | 29 Dec 2025 | ||
| George Michael Matus | CTO, Red Cat Holdings | $4,465,636 | 24 Dec 2024 | ||
| Leah Lunger | Chief Financial Officer | $4,399,108 | 03 Jan 2025 | ||
| Gregory Ralph French | 10%+ Owner | $4,285,824 | 22 Feb 2021 | ||
| Nicholas Reyland Liuzza Jr. | Director | $3,324,278 | -$1,529,769 | -32% | 20 May 2025 |
| Geoffrey Wayne Hitchcock | Chief Revenue Officer | $2,146,213 | 01 Oct 2025 | ||
| Allan Thomas Evans | Former COO | $1,285,111 | 31 Dec 2025 | ||
| Joseph D. Freedman | Director | $1,217,966 | -$1,105,500 | -48% | 30 Jun 2025 |
| Christopher R. Moe | Director | $579,026 | -$861,560 | -60% | 29 Sep 2025 |
| Joseph P. Hernon | Cfo | $318,933 | 02 Oct 2023 | ||
| Christian Ericson | Chief Operating Officer | $205,731 | 11 Mar 2026 | ||
| Mary Beth Long | Director | $94,878 | 16 May 2023 | ||
| Jonathan R. Read | Director | $62,154 | 19 Apr 2022 | ||
| Paul Funk II | Director | 02 Oct 2025 | |||
| Christian Spenst Morrison | Chief Financial Officer | 02 Dec 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christian Ericson | RCAT | Common Stock | Tax liability | -31.5% | -7,870 | 17,130 | 11 Mar 2026 | Direct | ||
| Christian Ericson | RCAT | Common Stock | Options Exercise | 25,000 | 25,000 | 11 Mar 2026 | Direct | |||
| Christian Ericson | RCAT | Restricted Stock Units | Options Exercise | -50% | -25,000 | 25,000 | 11 Mar 2026 | Direct | ||
| Jeffrey M. Thompson | RCAT | Common Stock | Gift | 4,750 | 4,750 | 29 Dec 2025 | Jointly held by spouse and son | |||
| Jeffrey M. Thompson | RCAT | Common Stock | Gift | -0.07% | -9,500 | 12,908,477 | 29 Dec 2025 | Direct | ||
| Christian Spenst Morrison | RCAT | Restricted Stock Units | Award | 30,150 | 30,150 | 02 Dec 2025 | Direct | |||
| Christian Ericson | RCAT | Restricted Stock Units | Award | 25,000 | 25,000 | 02 Dec 2025 | Direct | |||
| Paul Funk II | RCAT | Restricted Stock Units | Award | 868 | 868 | 02 Oct 2025 | Direct | |||
| Geoffrey Wayne Hitchcock | RCAT | Common Stock | Tax liability | -30.5% | -89,838 | 204,987 | 01 Oct 2025 | Direct | ||
| Geoffrey Wayne Hitchcock | RCAT | Common Stock | Options Exercise | 812.1% | 262,500 | 294,825 | 01 Oct 2025 | Direct | ||
| Geoffrey Wayne Hitchcock | RCAT | Restricted Stock Units | Options Exercise | -50% | -262,500 | 262,500 | 01 Oct 2025 | Direct | ||
| Christopher R. Moe | RCAT | Common Stock | Sale | -15.8% | $109,100 | $10.91 | -10,000 | 53,073 | 29 Sep 2025 | Direct |
| Christopher R. Moe | RCAT | Common Stock | Sale | -13.7% | $109,600 | $10.96 | -10,000 | 63,073 | 12 Sep 2025 | Direct |
| Christopher R. Moe | RCAT | Common Stock | Sale | -29.1% | $303,300 | $10.11 | -30,000 | 73,073 | 11 Sep 2025 | Direct |
| Christopher R. Moe | RCAT | Common Stock | Sale | -8.84% | $89,000 | $8.90 | -10,000 | 103,073 | 08 Sep 2025 | Direct |
| Christopher R. Moe | RCAT | Common Stock | Sale | -13% | $161,260 | $9.58 | -16,833 | 113,073 | 21 Aug 2025 | Direct |
| Christopher R. Moe | RCAT | Common Stock | Sale | -7.15% | $89,300 | $8.93 | -10,000 | 129,906 | 20 Aug 2025 | Direct |
| Jeffrey M. Thompson | RCAT | Common Stock | Tax liability | -0.36% | -46,297 | 12,901,208 | 18 Jul 2025 | Direct | ||
| Jeffrey M. Thompson | RCAT | Common Stock | Options Exercise | 3.54% | 441,983 | 12,938,958 | 18 Jul 2025 | Direct | ||
| Jeffrey M. Thompson | RCAT | Employee Stock Option (right to buy) | Options Exercise | -100% | -441,983 | 0 | 18 Jul 2025 | Direct | ||
| Joseph David Freedman | RCAT | Common Stock | Sale | -47.6% | $1,105,500 | $7.37 | -150,000 | 165,260 | 30 Jun 2025 | Direct |
| Joseph David Freedman | RCAT | Common Stock | Options Exercise | 90.8% | 150,000 | 315,260 | 30 Jun 2025 | Direct | ||
| Joseph David Freedman | RCAT | Employee Stock Option (right to buy) | Options Exercise | -100% | -150,000 | 0 | 30 Jun 2025 | Direct | ||
| Nicholas R. Liuzza Jr. | RCAT | Common Stock | Sale | -20.5% | $858,000 | $8.58 | -100,000 | 387,445 | 10 Jun 2025 | Direct |
| Nicholas R. Liuzza Jr. | RCAT | Common Stock | Exercise of in-the-money or at-the-money derivative security | 25.8% | 100,000 | 487,445 | 09 Jun 2025 | Direct | ||
| Nicholas R. Liuzza Jr. | RCAT | Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | -100% | -100,000 | 0 | 09 Jun 2025 | Direct | ||
| Nicholas R. Liuzza Jr. | RCAT | Common Stock | Sale | -20.6% | $671,769 | $6.70 | -100,309 | 387,445 | 21 May 2025 | Direct |
| Nicholas R. Liuzza Jr. | RCAT | Common Stock | Exercise of in-the-money or at-the-money derivative security | 25.8% | 100,000 | 487,754 | 20 May 2025 | Direct | ||
| Nicholas R. Liuzza Jr. | RCAT | Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | -50% | -100,000 | 100,000 | 20 May 2025 | Direct |